Framework Agreement For Producer Cell Line For GMP Viral Vector Packaging
What the buyer wrote
NHSBT's Clinical Biotechnology Centre has a requirement for specifying the user requirement for HEK293-derived production cell line for the GMP-production of viral vectors and other recombinant proteins. The CBC has an MHRA licence for the manufacture of investigational medicinal gene therapy and recombinant protein products for use in clinical trials. In order to manufacture GMP-grade viral vectors and recombinant proteins for clinical trials, a GMP-qualified producer cell line is required
Details
- What the buyer calls it
- Framework Agreement For Producer Cell Line For GMP Viral Vector Packaging
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 30 Apr 2021
- Work ends
- 30 Sep 2023
- Kind of work
- Health and social care
Who the buyer named
The buyer published a contact address on this notice.